Cover Image
市場調查報告書

婦產科系癌症治療藥的全球市場分析

Global Market Study on Gynaecological Cancer Drugs: North America to Lead the Global Market in Terms of Revenue during 2017 - 2026

出版商 Persistence Market Research 商品編碼 607620
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
婦產科系癌症治療藥的全球市場分析 Global Market Study on Gynaecological Cancer Drugs: North America to Lead the Global Market in Terms of Revenue during 2017 - 2026
出版日期: 2018年01月25日 內容資訊: 英文 170 Pages
簡介

本報告提供全球婦產科系癌症的治療藥的市場相關分析,提供疾病概要和市場結構,主要的推動及阻礙市場要素,市場規模·佔有率·成長率的變化與預測 (過去5年·今後10年份),各類藥物·各終端用戶·不同症狀·各流通管道及地區別詳細趨勢,目前市場競爭狀態,主要企業簡介等調查。

第1章 全球經濟的未來展望

第2章 摘要整理

第3章 全球婦產科系癌症治療藥市場概要

  • 簡介
  • 市場規模與其預測 (以金額為準,總計15年份)
    • 年度成長率
  • 市場動態
  • 供應鏈
  • 成本結構
  • 新的治療方法的出現
  • 開發平台上的婦產科系癌症治療藥
  • 婦產科系癌症的流行病學
  • 專利分析
  • 大環境分析
  • 產品生命週期
  • 服務供應商一覽
  • 主要打入市場企業的市場影響 (集中度地圖):各地區

第4章 全球婦產科系癌症治療藥市場分析與預測

  • 市場規模與其預測:各類藥物 (總計15年份)
    • 烷化劑
      • 市場收益額比較:各地區
      • 市場佔有率比較:各地區
      • 年度成長率比較:各地區
    • 植物性生物鹼
    • Anthracyclines
    • 抗腫瘤抗生素
    • 其他
  • 市場規模與其預測:各終端用戶 (總計15年份)
    • 醫院
    • 診療所
    • 癌症治療中心
    • 其他
  • 市場規模與其預測:不同症狀 (總計15年份)
    • 子宮頸癌症
    • 子宮癌症
    • 卵巢·輸卵管癌症
    • 外陰癌症
    • 陰道癌症
  • 市場規模與其預測:各流通管道 (總計15年份)
    • 院內藥局
    • 零售藥局
    • 線上藥局

第5章 北美的婦產科系癌症治療藥市場分析與預測

  • 市場展望
  • 母體市場未來展望
  • 目標市場的未來展望
  • 市場收益額比較:各國 (總計15年份)
    • 美國
    • 加拿大
  • 市場收益額比較:各類藥物
  • 市場收益額比較:各終端用戶
  • 市場收益額比較:不同症狀
  • 市場收益額比較:各流通管道

第6章 南美的婦產科系癌症治療藥市場分析與預測

  • 市場收益額比較:各國 (總計15年份)
    • 巴西
    • 墨西哥
    • 其他

第7章 歐洲的婦產科系癌症治療藥市場分析與預測

  • 市場收益額比較:各國 (總計15年份)
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他

第8章 日本的婦產科系癌症治療藥市場分析與預測

  • 市場收益額比較 (總計15年份)

第9章 亞太地區 (日本以外)的婦產科系癌症治療藥市場分析與預測

  • 市場收益額比較:各國 (總計15年份)
    • 中國
    • 印度
    • 泰國
    • 新加坡
    • 澳洲
    • 其他

第10章 中東·非洲的婦產科系癌症治療藥市場分析與預測

  • 市場收益額比較:各國 (總計15年份)
    • 波灣合作理事會 (GCC) 各國
    • 南非
    • 以色列
    • 其他

第11章 市場佔有率,競爭環境,企業簡介

  • 各企業市場佔有率
  • 競爭環境
  • 企業簡介
    • Roche Holdings AG
    • AstraZeneca
    • Sanofi
    • Eli Lilly & Co.
    • Pfizer Inc.
    • 武田藥品工業
    • Bristol-Myers Squibb
    • Merck & Co.
    • Dr Reddy's Laboratories
    • Johnson & Johnson (Alza Corporation)
    • GlaxoSmithKline (GSK)

第12章 分析方法

第13章 一次·二級資訊來源

第14章 前提條件·簡稱一覽

第15章 免責聲明

目錄

Global Gynaecological Cancer Drugs Market- Overview

The surge of innovation in gynaecological cancer treatments is attracting all the major participants in the market for cancer drugs. Scientific advances are leading to the new treatment options in the market. Hence, the gynaecological cancer drugs market is also expected to see a significant growth in the coming years. However, in the diversified regulatory systems, the healthcare industry in most of the countries are still struggling to adapt and embrace new treatment options. Moreover, the absence of advanced diagnostic and treatment infrastructure and poor financing mechanisms especially in the developing countries is hampering the market growth.

Gynaecological Cancer is still an area of active interest with increasing focus on targeted therapies. Several, targeted therapies are in the development process. Meanwhile, the concept of personalized medicine is gaining traction in the global gynaecological cancer drugs market with increasing number of clinical trials.

Global Gynaecological Cancer Drugs Market- Research Methodology

The report on the global gynaecological cancer drugs market offers key insights on various trends and factors driving the market. The primary and secondary research was done to derive at the various factors impacting the market growth along with the data on the market. The report also offers market segmentation and performance of the market in various regions. The report also includes both qualitative and quantitative information based on the opinions of industry experts, this helps in identifying opportunities in the market. The report also comprises CAGR, market share, year-on-year growth, revenue generated in the past and the forecast on the market from 2017 to 2026.

The report also highlights current and upcoming trends, drivers, opportunities in the market and factors hampering the market growth. These market dynamics show the current scenario in the global gynaecological cancer drugs market. In-depth analysis of the drugs in the market helps in understanding future growth and opportunities in the market.

Market attractiveness analysis sheds light on the investment opportunities in the market. A study also includes SWOT analysis and Porter's five force analysis to get an idea of the overall market. The report also talks about latest developments and new technologies with the capacity to transform the market in the next few years.

The leading market players operating in the global gynaecological cancer drugs market are also offered in the report. In-depth information on long-term and short-term strategies along with company and financial overview and product portfolio are also included in the competition analysis. The report also focuses on regulations imposed on the gynaecological cancer drugs market.

The global gynaecological cancer drugs market is segmented on the basis of drug class, end users, indication, distribution channel, and region. The drugs class is segmented into alkylating agent, plant alkaloid, anthracyclines, antitumor antibiotic, and other drug class. Based on the end users, the market is segmented into hospitals, clinics, specialized cancer treatment centers, and other end users.

On the basis of indication, the market segment includes cervical cancer, uterine cancer, ovarian & fallopian tube cancer, vulvar cancer, and vaginal cancer. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and e-commerce.

Region-wise, the market segment includes Latin America, Japan, North America, Asia Pacific Excluding Japan (APEJ), Europe, and the Middle East and Africa (MEA).

Table of Contents

1. Global Economic Outlook

2. Global Gynaecological Cancer Drugs Market - Executive Summary

3. Global Gynaecological Cancer Drugs Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Gynaecological Cancer Drugs Market Taxonomy
    • 3.1.2. Global Gynaecological Cancer Drugs Market Definition
  • 3.2. Global Gynaecological Cancer Drugs Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Gynaecological Cancer Drugs Market Y-o-Y Growth
  • 3.3. Global Gynaecological Cancer Drugs Market Dynamics
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Cancer service provision by level of healthcare
  • 3.7. Gynaecological cancer drugs in pipeline
  • 3.8. Use of Nanomedicine for the treatment of Gynaecological Cancers
  • 3.9. Gynaecological Cancer Epidemiology
  • 3.10. Patent Analysis
  • 3.11. PESTL Analysis
  • 3.12. Product Lifecycle
  • 3.13. Service Provider List
  • 3.14. Key Participants Market Presence (Intensity Map) By Region

4. Global Gynaecological Cancer Drugs Market Analysis and Forecast 2012-2026

  • 4.1. Global Gynaecological Cancer Drugs Market Size and Forecast By Drug Class, 2012-2026
    • 4.1.1. Alkylating Agent Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Plant Alkaloid Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Anthracyclines Market Size and Forecast, 2012-2026
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
    • 4.1.4. Antitumor Antibiotic Market Size and Forecast, 2012-2026
      • 4.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.4.2. Market Share Comparison, By Region
      • 4.1.4.3. Y-o-Y growth Comparison, By Region
    • 4.1.5. Other Drug Class Market Size and Forecast, 2012-2026
      • 4.1.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.5.2. Market Share Comparison, By Region
      • 4.1.5.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Gynaecological Cancer Drugs Market Size and Forecast By End User, 2012-2026
    • 4.2.1. Hospitals Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Clinics Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region
    • 4.2.4. Other End Users Market Size and Forecast, 2012-2026
      • 4.2.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.4.2. Market Share Comparison, By Region
      • 4.2.4.3. Y-o-Y growth Comparison, By Region
  • 4.3. Global Gynaecological Cancer Drugs Market Size and Forecast By Indication, 2012-2026
    • 4.3.1. Cervical Cancer Market Size and Forecast, 2012-2026
      • 4.3.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.1.2. Market Share Comparison, By Region
      • 4.3.1.3. Y-o-Y growth Comparison, By Region
    • 4.3.2. Uterine Cancer Market Size and Forecast, 2012-2026
      • 4.3.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.2.2. Market Share Comparison, By Region
      • 4.3.2.3. Y-o-Y growth Comparison, By Region
    • 4.3.3. Ovarian & Fallopian Tube Cancer Market Size and Forecast, 2012-2026
      • 4.3.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.3.2. Market Share Comparison, By Region
      • 4.3.3.3. Y-o-Y growth Comparison, By Region
    • 4.3.4. Vulvar Cancer Market Size and Forecast, 2012-2026
      • 4.3.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.4.2. Market Share Comparison, By Region
      • 4.3.4.3. Y-o-Y growth Comparison, By Region
    • 4.3.5. Vaginal Cancer Market Size and Forecast, 2012-2026
      • 4.3.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.5.2. Market Share Comparison, By Region
      • 4.3.5.3. Y-o-Y growth Comparison, By Region
  • 4.4. Global Gynaecological Cancer Drugs Market Size and Forecast By Distribution Channel, 2012-2026
    • 4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
      • 4.4.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.4.1.2. Market Share Comparison, By Region
      • 4.4.1.3. Y-o-Y growth Comparison, By Region
    • 4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
      • 4.4.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.4.2.2. Market Share Comparison, By Region
      • 4.4.2.3. Y-o-Y growth Comparison, By Region
    • 4.4.3. Market Size and Forecast, 2012-2026
      • 4.4.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.4.3.2. Market Share Comparison, By Region
      • 4.4.3.3. Y-o-Y growth Comparison, By Region

5. North America Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 5.6. Revenue (US$ Mn) Comparison, By End User
  • 5.7. Revenue (US$ Mn) Comparison, By Indication
  • 5.8. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 6.6. Revenue (US$ Mn) Comparison, By End User
  • 6.7. Revenue (US$ Mn) Comparison, By Indication
  • 6.8. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 7.6. Revenue (US$ Mn) Comparison, By End User
  • 7.7. Revenue (US$ Mn) Comparison, By Indication
  • 7.8. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Japan Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 8.1. Japan Outlook
  • 8.2. Japan Parent Market Outlook
  • 8.3. Japan Target Market Outlook
  • 8.4. Revenue (US$ Mn) Comparison, 2012-2026
    • 8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 8.6. Revenue (US$ Mn) Comparison, By End User
  • 8.7. Revenue (US$ Mn) Comparison, By Indication
  • 8.8. Revenue (US$ Mn) Comparison, By Distribution Channel

9. APEJ Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 9.1. APEJ Outlook
  • 9.2. APEJ Parent Market Outlook
  • 9.3. APEJ Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 9.6. Revenue (US$ Mn) Comparison, By End User
  • 9.7. Revenue (US$ Mn) Comparison, By Indication
  • 9.8. Revenue (US$ Mn) Comparison, By Distribution Channel

10. MEA Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026

  • 10.1. MEA Outlook
  • 10.2. MEA Parent Market Outlook
  • 10.3. MEA Target Market Outlook
  • 10.4. Revenue (US$ Mn) Comparison, By Country
    • 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 10.5. Revenue (US$ Mn) Comparison, By Drug Class
  • 10.6. Revenue (US$ Mn) Comparison, By End User
  • 10.7. Revenue (US$ Mn) Comparison, By Indication
  • 10.8. Revenue (US$ Mn) Comparison, By Distribution Channel

11. Global Gynaecological Cancer Drugs Market Company Share, Competition Landscape and Company Profiles

  • 11.1. Company Share Analysis
  • 11.2. Competition Landscape
  • 11.3. Company Profiles
    • 11.3.1. Roche Holdings AG
    • 11.3.2. AstraZeneca
    • 11.3.3. Sanofi
    • 11.3.4. Eli Lilly & Co.
    • 11.3.5. Pfizer Inc.
    • 11.3.6. Takeda Pharmaceuticals Co. Ltd.
    • 11.3.7. Bristol-Myers Squibb
    • 11.3.8. Merck & Co.
    • 11.3.9. Dr Reddy's Laboratories
    • 11.3.10. Johnson & Johnson (Alza Corporation)
    • 11.3.11. GlaxoSmithKline (GSK)

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

List of Tables

  • TABLE 1: Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2012-2017
  • TABLE 2: Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2018-2026
  • TABLE 3: Global Gynaecological Cancer Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4: Global Alkylating Agent Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5: Global Alkylating Agent Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6: Global Alkylating Agent Segment Market Share, By Region 2012-2017
  • TABLE 7: Global Alkylating Agent Segment Market Share, By Region 2018-2026
  • TABLE 8: Global Alkylating Agent Segment Y-o-Y, By Region 2017-2026
  • TABLE 9: Global Plant Alkaloid Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10: Global Plant Alkaloid Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11: Global Plant Alkaloid Segment Market Share, By Region 2012-2017
  • TABLE 12: Global Plant Alkaloid Segment Market Share, By Region 2018-2026
  • TABLE 13: Global Plant Alkaloid Segment Y-o-Y, By Region 2017-2026
  • TABLE 14: Global Anthracyclines Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15: Global Anthracyclines Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16: Global Anthracyclines Segment Market Share, By Region 2012-2017
  • TABLE 17: Global Anthracyclines Segment Market Share, By Region 2018-2026
  • TABLE 18: Global Anthracyclines Segment Y-o-Y, By Region 2017-2026
  • TABLE 19: Global Antitumor Antibiotic Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20: Global Antitumor Antibiotic Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21: Global Antitumor Antibiotic Segment Market Share, By Region 2012-2017
  • TABLE 22: Global Antitumor Antibiotic Segment Market Share, By Region 2018-2026
  • TABLE 23: Global Antitumor Antibiotic Segment Y-o-Y, By Region 2017-2026
  • TABLE 24: Global Other Drug Class Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25: Global Other Drug Class Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26: Global Other Drug Class Segment Market Share, By Region 2012-2017
  • TABLE 27: Global Other Drug Class Segment Market Share, By Region 2018-2026
  • TABLE 28: Global Other Drug Class Segment Y-o-Y, By Region 2017-2026
  • TABLE 29: Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30: Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31: Global Hospitals Segment Market Share, By Region 2012-2017
  • TABLE 32: Global Hospitals Segment Market Share, By Region 2018-2026
  • TABLE 33: Global Hospitals Segment Y-o-Y, By Region 2017-2026
  • TABLE 34: Global Clinics Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35: Global Clinics Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36: Global Clinics Segment Market Share, By Region 2012-2017
  • TABLE 37: Global Clinics Segment Market Share, By Region 2018-2026
  • TABLE 38: Global Clinics Segment Y-o-Y, By Region 2017-2026
  • TABLE 39: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
  • TABLE 42: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
  • TABLE 43: Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
  • TABLE 44: Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45: Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46: Global Other End Users Segment Market Share, By Region 2012-2017
  • TABLE 47: Global Other End Users Segment Market Share, By Region 2018-2026
  • TABLE 48: Global Other End Users Segment Y-o-Y, By Region 2017-2026
  • TABLE 49: Global Cervical Cancer Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50: Global Cervical Cancer Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51: Global Cervical Cancer Segment Market Share, By Region 2012-2017
  • TABLE 52: Global Cervical Cancer Segment Market Share, By Region 2018-2026
  • TABLE 53: Global Cervical Cancer Segment Y-o-Y, By Region 2017-2026
  • TABLE 54: Global Uterine Cancer Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 55: Global Uterine Cancer Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 56: Global Uterine Cancer Segment Market Share, By Region 2012-2017
  • TABLE 57: Global Uterine Cancer Segment Market Share, By Region 2018-2026
  • TABLE 58: Global Uterine Cancer Segment Y-o-Y, By Region 2017-2026
  • TABLE 59: Global Ovarian & Fallopian Tube Cancer Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 60: Global Ovarian & Fallopian Tube Cancer Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 61: Global Ovarian & Fallopian Tube Cancer Segment Market Share, By Region 2012-2017
  • TABLE 62: Global Ovarian & Fallopian Tube Cancer Segment Market Share, By Region 2018-2026
  • TABLE 63: Global Ovarian & Fallopian Tube Cancer Segment Y-o-Y, By Region 2017-2026
  • TABLE 64: Global Vulvar Cancer Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 65: Global Vulvar Cancer Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 66: Global Vulvar Cancer Segment Market Share, By Region 2012-2017
  • TABLE 67: Global Vulvar Cancer Segment Market Share, By Region 2018-2026
  • TABLE 68: Global Vulvar Cancer Segment Y-o-Y, By Region 2017-2026
  • TABLE 69: Global Vaginal Cancer Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 70: Global Vaginal Cancer Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 71: Global Vaginal Cancer Segment Market Share, By Region 2012-2017
  • TABLE 72: Global Vaginal Cancer Segment Market Share, By Region 2018-2026
  • TABLE 73: Global Vaginal Cancer Segment Y-o-Y, By Region 2017-2026
  • TABLE 74: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 75: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 76: Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 77: Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 78: Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 79: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 80: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 81: Global Retail Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 82: Global Retail Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 83: Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 84: Global E-commerce Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 85: Global E-commerce Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 86: Global E-commerce Segment Market Share, By Region 2012-2017
  • TABLE 87: Global E-commerce Segment Market Share, By Region 2018-2026
  • TABLE 88: Global E-commerce Segment Y-o-Y, By Region 2017-2026
  • TABLE 89: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 90: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 91: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 92: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 93: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 94: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 95: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 96: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 97: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 98: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 99: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 100: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 101: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 102: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 103: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 104: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 105: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 106: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 107: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 108: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 109: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 110: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 111: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 112: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 113: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 114: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 115: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 116: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 117: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 118: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 119: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 120: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 121: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 122: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 123: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 124: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 125: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 126: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 127: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 128: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 129: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 130: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 131: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 132: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 133: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 134: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 135: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 136: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 137: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 138: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 139: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • TABLE 140: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • TABLE 141: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • TABLE 142: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • TABLE 143: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • TABLE 144: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • TABLE 145: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 146: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 147: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 148: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026

List of Figures

  • FIG. 1: Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2012-2017
  • FIG. 2: Global Gynaecological Cancer Drugs Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3: Global Gynaecological Cancer Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4: Global Alkylating Agent Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5: Global Alkylating Agent Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6: Global Alkylating Agent Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7: Global Plant Alkaloid Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8: Global Plant Alkaloid Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9: Global Plant Alkaloid Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10: Global Anthracyclines Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11: Global Anthracyclines Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12: Global Anthracyclines Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13: Global Antitumor Antibiotic Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14: Global Antitumor Antibiotic Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15: Global Antitumor Antibiotic Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16: Global Other Drug Class Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17: Global Other Drug Class Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18: Global Other Drug Class Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19: Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20: Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22: Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23: Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24: Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27: Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28: Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29: Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31: Global Cervical Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32: Global Cervical Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33: Global Cervical Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34: Global Uterine Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 35: Global Uterine Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 36: Global Uterine Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 37: Global Ovarian & Fallopian Tube Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 38: Global Ovarian & Fallopian Tube Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 39: Global Ovarian & Fallopian Tube Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 40: Global Vulvar Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 41: Global Vulvar Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 42: Global Vulvar Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 43: Global Vaginal Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 44: Global Vaginal Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 45: Global Vaginal Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 46: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 47: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 48: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 49: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 50: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 51: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 52: Global E-commerce Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 53: Global E-commerce Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 54: Global E-commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 55: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 56: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 57: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 58: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 59: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • FIG. 60: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 61: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 62: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 63: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 64: North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 65: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 66: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 67: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 68: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 69: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • FIG. 70: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 71: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 72: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 73: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 74: Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 75: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 76: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 77: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 78: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 79: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • FIG. 80: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 81: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 82: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 83: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 84: Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 85: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 86: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 87: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 88: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 89: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 90: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 91: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 92: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 93: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 94: Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 95: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 96: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 97: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 98: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 99: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • FIG. 100: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 101: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 102: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 103: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 104: APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 105: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
  • FIG. 106: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
  • FIG. 107: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
  • FIG. 108: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
  • FIG. 109: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
  • FIG. 110: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
  • FIG. 111: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 112: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 113: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 114: MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
Back to Top